Long-Term (104 Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials
Servizos
Servizos
Data de publicación
2015Título da revista
Arthritis and Rheumatology
Tipo de contido
Publicación de congreso
